BRIEF-Intelgenx Technologies to start phase 1 trial of Montelukast
July 13 (Reuters) - Intelgenx Technologies Corp
* Intelgenx to initiate phase 1 trial of Montelukast
* Intelgenx expects results from phase 1 trial to be available in September 2016
* Will be seeking partnership or alliance opportunity to complete remaining developmental work, commercialization of product Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.